This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN slid 1.18% to $2.51 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 3.06% to 3,911.74 and the Dow Jones Industrial Average DJIA rising 2.68% to 31,500.68. The stock's fall snapped a four-day winning streak. Ocugen Inc. closed $15.14 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. ADVM fell 1.85% to $1.06, Ocular Therapeutix Inc. OCUL fell 5.23% to $3.99, and Kodiak Sciences Inc. KOD rose 0.56% to $9.04. Trading volume (9.0 M) eclipsed its 50-day average volume of 7.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 24, 2022.
(END) Dow Jones Newswires
June 24, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.